NCT06857344 (AAS-GE) is a NA clinical trial of AI Controlled General Anesthesia in Anesthesia Induction, sponsored by Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd..

What drugs are being tested in NCT06857344?

Interventions in NCT06857344: AI Controlled General Anesthesia, General Anesthesia (GA).

What condition does NCT06857344 study?

NCT06857344 studies Anesthesia Induction.

Is NCT06857344 still recruiting?

NCT06857344 is currently recruiting now. Last updated 15 August 2025.

Last reviewed 2025-08-15 · How we verify

NCT06857344: AAS-GE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Reinforcement Learned Automatic Anesthesia System During Painless Gastrointestinal Endoscopy

Recruiting now NA Last updated 15 August 2025

What this trial tests

NA trial testing AI Controlled General Anesthesia in Anesthesia Induction in 164 participants. Currently enrolling.

Timeline

1 May 2025

Primary endpoint
1 September 2025

1 October 2025

Quick facts

Lead sponsor	Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	164
Start date	1 May 2025
Primary completion	1 September 2025
Estimated completion	1 October 2025
Sites	5 locations across China

Drugs / interventions tested

AI Controlled General Anesthesia
General Anesthesia (GA) — full drug profile →

Conditions studied

Anesthesia Induction — all drugs for Anesthesia Induction →

Sponsor

Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.

Who can join

Adults 18 to 65, any sex, with Anesthesia Induction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to compare the performance difference between trained model and clinical professionals in anesthesia control during gastrointestinal endoscopy. The participants would include adults aged between 18-65 years old with ASA scores I-II. The main questions it aims to answer are: * Can AI model successfully and safely perform anesthesia during gastrointestinal endoscopy? * Researchers hypothesis that anesthesia performed by professionals is not inferior to those performed by AI model. The researchers will compare the results of the AI group with the traditional group to see if both groups have similar success rates in performing anesthesia. Participants will fast for 8 hours before the procedure, and drinking water will be prohibited for 2 hours after taking the intestinal purgatives.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Reinforcement learning based automated anesthesia system for gastrointestinal endoscopy with a multicenter randomized trial.
Bing HL, Wang Y, Li SY, Li YW, et al · · 2026 · PMID 42056274 · DOI 10.1038/s41746-026-02657-8

Verify or expand the search:

Other trials of AI Controlled General Anesthesia

Trials testing the same drug.

NCT07132151 — Reinforcement Learned Automated Anesthesia Systems During Painless Abortion · NA · not yet recruiting

Other recruiting trials for Anesthesia Induction

Currently open trials in the same condition.

NCT07365345 — Frequency of Electrical Acupoint Stimulation on Hypotension in TAVR Patients · NA · recruiting
NCT06841822 — The Impact of Ultrasound-Guided Superficial and Deep Paravertebral Nerve Blocks at the Superior Costotransverse Ligament · NA · recruiting
NCT06639737 — Preoperative Blood Volume Optimization Using Transthoracic Echocardiography · NA · recruiting
NCT06144177 — Induction in the Dark · Phase 4 · recruiting

Other Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd. trials

Trials by the same sponsor.

NCT07132151 — Reinforcement Learned Automated Anesthesia Systems During Painless Abortion · NA · not yet recruiting
NCT06382961 — Postoperative Dexmedetomidine in Prevention of Postoperative Delirium · NA · completed
NCT05952050 — Different Administration Routes of Dexmedetomidine on Postoperative Delirium · NA · unknown
NCT05945004 — ChatGPT v.s. Human in Writing a Preoperative Visit Sheet · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06857344 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.
Last refreshed: 15 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06857344.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing